FDA Adverse Event Malfunction Summary report: N

SAFSITE®

MDR report key: 22792963 · Received August 13, 2025

Report

Report Number
2521402-2025-00411
Event Type
Malfunction
Date Received
August 13, 2025
Date of Event
July 24, 2025
Report Date
October 21, 2025
Manufacturer
B. BRAUN MEDICAL INC.
Product Code
FPA
UDI-DI
04022495769862
PMA / PMN Number
K942988
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THIS REPORT HAS BEEN IDENTIFIED AS B. BRAUN MEDICAL INTERNAL REPORT NUMBER (B)(4). TWO USED SAMPLES WERE PROVIDED FOR INVESTIGATION. UPON EVALUATION OF THE UNITS, NO VISUAL DEFECTS WERE OBSERVED. THE SAMPLE WAS LEAK TESTED WITH NO LEAKAGE NOTED. THE REPORTED ISSUE WAS NOT CONFIRMED. ALL A REVIEW OF THE DISCREPANCY MANAGEMENT SYSTEM (DSMS) DATABASE WAS PERFORMED FOR THE REPORTED LOT NUMBER AND NO ABNORMALITIES OR NON-CONFORMANCES WERE NOTED DURING THE IN PROCESS OR FINAL PRODUCT INSPECTION. FIVE RETAINS FROM THE REPORTED LOT NUMBER WERE TESTED AND PASSED PER SPECIFICATION. WE WILL MAINTAIN THIS REPORT FOR FURTHER REFERENCES AND CONTINUE TO MONITOR OTHER REPORTS FOR SIMILAR OCCURRENCES. IF ANY ADDITIONAL PERTINENT INFORMATION BECOMES AVAILABLE, A FOLLOW UP WILL BE SUBMITTED.

Additional Manufacturer Narrative · 0

THIS REPORT HAS BEEN IDENTIFIED AS B. BRAUN MEDICAL INTERNAL REPORT NUMBER (B)(4). THE INVESTIGATION IS ONGOING AT THIS TIME. A FOLLOW UP WILL BE SUBMITTED WHEN THE INVESTIGATION RESULTS BECOME AVAILABLE.

Description of Event or Problem · 0

AS REPORTED BY THE USER FACILITY: REASON OF COMPLAINT: BLOOD SEEN TO BE OOZING FROM THE SAFSITE VALVE AFTER DISCONNECTION OF HEIDELBERG EXTENSION TUBING. CAP PLACED ON SAFSITE VALVE TO STOP THE BACK FLOW OF BLOOD.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
75975 SAFSITE® SET, ADMINISTRATION, INTRAVASCULAR FPA B. BRAUN MEDICAL INC. 0061968348 04022495769862

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown